Table 9 Comparison of demographics between patients who had an adverse outcome (death) vs. those who were alive

 Mean ± SD

54.75 ± 11.05

53.00 ± 17.18

0.347^b

0.731

NS

 Range

32–78

34–82

 Male

13 (54.2%)

4 (44.4%)

0.248^a

0.619

NS

 Female

11 (45.8%)

5 (55.6%)

 Not working

7 (29.2%)

1 (11.1%)

2.855^a

0.582

NS

 Housewife

11 (45.8%)

5 (55.6%)

 Employer

2 (8.3%)

2 (22.2%)

 Worker

2 (8.3%)

1 (11.1%)

 On pension

2 (8.3%)

0 (0.0%)

Smoking

6 (25.0%)

2 (22.2%)

0.028^a

0.868

NS

Diabetes

21 (87.5%)

9 (100.0%)

1.238^a

0.266

NS

Controlled

9 (42.9%)

2 (22.2%)

1.155^a

0.282

NS

Newly diagnosed

1 (4.8%)

1 (11.1%)

0.408^a

0.523

NS

DKA on admission

2 (9.5%)

6 (66.7%)

10.519^a

0.001

HS

Immunosuppressive drugs

0 (0.0%)

0 (0.0%)

Chronic liver disease

1 (4.2%)

0 (0.0%)

0.387^a

0.534

NS

Chronic kidney disease

1 (4.2%)

0 (0.0%)

0.387^a

0.534

NS

Hematologic malignancy

0 (0.0%)

0 (0.0%)

–

–

–

Prolonged antibiotic or antiviral therapy

5 (20.8%)

4 (44.4%)

1.840^a

0.175

NS

Autoimmune disease

1 (4.2%)

0 (0.0%)

0.387^a

0.534

NS

Prolonged steroid use

29 (88%)

0 (0.0%)

1.238^a

0.266

NS

Chemotherapy

0 (0.0%)

0 (0.0%)

–

–

–

Thrombocytopenia

2 (8.3%)

0 (0.0%)

0.798^a

0.372

NS